Search
for
Sort by
Research 391–420 of 1000+
- Autoimmune disorders associated with type 1 diabetes: clinical overview and principles of management
- Review on Calotropis Gigantea as a Topically used Plant
- 1614 A systematic review and meta-analysis of comorbidities in lichen sclerosus with a screening recommendation
- Baricitinib for alopecia areata
- Protein-Losing Enteropathy as the First Presentation of Systemic Lupus Erythematosus in a Resource-Limited Setting in Sri Lanka: A Case Report
- AN OVERVIEW ON THE PHARMACOLOGICAL ACTIVITIES OF Myrtus Communis L.
- CLINICAL SPECTRUM AND IMMUNOLOGICAL PROFILE OF PATIENTS WITH MIXED CONNECTIVE TISSUE DISEASE PRESENTING IN A TERTIARY CARE HOSPITAL
- Hair Masks Based on Keratin and Collagen
- Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib
- Advantages and Clinical Applications of Lyophilized Platelet-Rich Plasma in Various Disease Conditions: A Review
- An Overview of Analeptic Applications of Omega-3 Fatty Acids
- Hepatitis Lupus in Systemic Lupus Erythematosus in Male Patients
- ARTICLE REVIEW: MYRTUS COMMUNIS LINN AND ITS MEDICAL AND BIOLOGICAL US
- Alopecia Areata: literature review
- Life Sciences Discovery and Technology Highlights
- CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS FROM A TERTIARY CARE CENTRE IN COASTAL KERALA
- Ethnobotanical knowledge about herbals used by tribes of Kerala and Tamil Nadu with special reference to Begonia malabarica Lam.
- Powder microscopy and phytochemical screening on stem bark and leaves of Buxus wallichiana Baill - Buxaceae
- Medications
- Formulation and evaluation of dermatological products for topical delivery / by Mahima Manian
- Contents
- Esssentials of Systemic Lupus Erythematosus
- Symptoms: Pruritic Skin Lesions
- ESCITALOPRAM
- A national ethics committee
- Aloe Vera
- [Favorable effects of estrogens and progesterones on general diseases].
- DEVELOPMENT OF THE EMULGE LFOR THE ANDROGENIC ALOPECIA TREATMENT
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases